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Background. Translation deregulation is an important mechanism that causes aberrant cell growth, proliferation and survival.
eIF4E, the mRNA 59 cap-binding protein, plays a major role in translational control. To understand how eIF4E affects cell
proliferation and survival, we studied mRNA targets that are translationally responsive to eIF4E. Methodology/Principal
Findings. Microarray analysis of polysomal mRNA from an eIF4E-inducible NIH 3T3 cell line was performed. Inducible
expression of eIF4E resulted in increased translation of defined sets of mRNAs. Many of the mRNAs are novel targets, including
those that encode large- and small-subunit ribosomal proteins and cell growth-related factors. In addition, there was
augmented translation of mRNAs encoding anti-apoptotic proteins, which conferred resistance to endoplasmic reticulum-
mediated apoptosis. Conclusions/Significance. Our results shed new light on the mechanisms by which eIF4E prevents
apoptosis and transforms cells. Downregulation of eIF4E and its downstream targets is a potential therapeutic option for the
development of novel anti-cancer drugs.
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INTRODUCTION
Post-transcriptional control of gene expression at the level of
translation has emerged as an important cellular function in
normal development [1] and aberrations in this process leads to
diseases including cancer [2,3]. Translation rates in vertebrates are
modulated by a wide variety of extracellular stimuli including
hormones, mitogens, growth factors, nutrient availability and
stress, and are coupled with cell cycle progression and cell growth
[for reviews, see: [4,5,6]]. Translation is the most energy-
consuming process in the cell [6] and thus, not surprisingly,
translation rates are tightly regulated, mainly at the level of
initiation [7]. All nuclear-encoded cellular mRNAs possess a cap
structure, m
7GpppN (where N is any nucleotide), at their 59
terminus [7]. A key player in the regulation of translation initiation
is the mRNA 59 cap–binding protein, eIF4E, which is the limiting
component of the eIF4F initiation complex. In addition to eIF4E,
this complex contains two other subunits: eIF4A (an ATP-
dependent helicase) and eIF4G (a large scaffolding protein), which
contains docking sites for the other subunits and additional
proteins. eIF4F is directed to the 59 end of the mRNA via eIF4E
and is believed to act through eIF4A (along with eIF4B) to unwind
the mRNA 59 secondary structure to facilitate ribosome binding
[7].
Translational control plays an important role in aberrant cell
growth and cancer development [reviewed in [8,9]]. Over-
expression of eIF4E results in transformation of immortalized
rodent cells [10] and human mammary epithelial cells [11]. eIF4E
also cooperates with Myc and E1A to transform rat embryo
fibroblasts [12]. Furthermore, antisense- and RNAi-mediated
decreases in eIF4E expression results in the inhibition of cell
growth and reversion of the transformed phenotype of several cell
lines [13–16]. eIF4E is also oncogenic in vivo, as eIF4E promotes
the development of lymphomas and several types of carcinomas in
mice [17,18]. eIF4E protein levels are substantially elevated in
many cancers including colon, breast, bladder, lung, prostate,
gastrointestinal tract and head and neck cancers; Hodgkin’s
lymphomas and neuroblastomas [4,9,19].
Because eIF4E is the least-abundant initiation factor in most
cells [20,21], it was suggested that mRNAs ‘‘compete’’ for the
limiting amounts of eIF4E in the cell [22,23]. Overexpression of
eIF4E results in enhanced translation of mRNAs containing
extensive secondary structure in their 59 untranslated regions
(UTRs; [23]). These mRNAs encode proteins such as ornithine
decarboxylase (ODC), vascular endothelial growth factor (VEGF)
and fibroblast growth factor 2 (FGF2), which are strongly
implicated in cell growth, proliferation and survival [reviewed in
[9,19,24]]. Earlier studies were carried out to systematically
identify translation eIF4E targets in cells constitutively over-
expressing eIF4E either directly [25], or indirectly through the
activation of upstream signaling components that converge on
eIF4E [26]. The present study exploits an eIF4E-inducible NIH
3T3 cell line [27], and focuses on very early genome-wide effects
of eIF4E overexpression on the recruitment of ribosomes to the
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effects in established cell lines. Induction of eIF4E expression
resulted in increased translation of a group of mRNAs that encode
small- and large-subunit ribosomal proteins, anti-apoptotic
proteins and cell growth–related factors.
RESULTS
Induction of eIF4E in an NIH 3T3 fibroblast cell line
To identify mRNAs whose translation is affected by overexpres-
sion of eIF4E, an NIH 3T3 cell line overexpressing eIF4E in
a tetracycline-dependent manner was used (3T3-tTA-eIF4E; [27]).
eIF4E induction was readily detectable 5 hr after tetracycline
removal, and eIF4E levels dramatically increased after 12 hr
(Fig. 1A). The eIF4E protein was induced about 3-fold after 5 hr,
which is physiologically relevant, as eIF4E amounts can be
increased upon cell stimulation and in tumors to a similar extent
[28,29]. To assess the translational effect of eIF4E overexpression
and to avoid secondary effects (especially transcriptional), a
relatively short induction time of 5 hr was chosen followed by
polyribosome fractionation and microarray analysis. Polysome
profiles for both induced (-tet 5 hrs) and uninduced 3T3-tTA and
3T3-tTA-eIF4E cells overlapped and showed no significant
differences (data not shown). A characteristic profile of 3T3-tTA
and 3T3-tTA-eIF4E cells is depicted in Fig. 1B. The 40S and 60S
ribosome subunits and 80S ribosomes typically sedimented
between fractions 3 and 11 in the sucrose density gradients,
whereas polysomes sedimented between fractions 14 and 24
(Fig. 1B). Denaturing agarose gel analysis showed that the 28S
rRNA appeared in fractions 6 and 7, where the 60S subunit
sedimented (Fig. 1C). Fractions 18–24, which contain the heavier
polysomes, were pooled for microarray analysis.
Microarray analysis of total RNA and polysome
fractions
Four sets of microarray experiments were conducted. Two
examined the effect of eIF4E induction on transcription and
translation in the 3T3-tTA-eIF4E cell line (Fig. 1D, schemes 1 and
2). The other two analyses were conducted using the parental cell
line 3T3-tTA which served as a control (Fig. 1D, schemes 3 and 4).
First, we examined the effect of eIF4E on total mRNA levels. Total
mRNA from uninduced versus induced 3T3-tTA-eIF4E was
compared to RNA from uninduced versus induced 3T3-tTA. This
analysis identified transcriptional activation that occurs in 3T3-
tTA-eIF4E cells when eIF4E is induced but not in 3T3-tTA cells.
Figure 1. Induction of eIF4E in NIH 3T3 fibroblast cells and microarray analysis. A) eIF4E overexpression was induced by culturing 3T3-tTA-eIF4E
cells in a tetracycline free medium. Immunoblots for eIF4E and b-actin were performed. B) A characteristic fractionation profile of 3T3-tTA and 3T3-
tTA-eIF4E cells is depicted. Absorbance at 254 nm was monitored. C) Fractions from 3T3-tTA and 3T3-tTA-eIF4E (induced) cells were analyzed on
a denaturing agarose gel to visualize the 18S and 28S rRNAs. D) The experimental design used for microarray analysis is shown.
doi:10.1371/journal.pone.0000242.g001
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a limited subset of transcripts was changed in transcriptome
abundance (from a total of 27 unique annotated genes, 22 were
induced and 5 repressed at a q-value,0.1 and 1.3 fold-change cut
off). These changes are probably secondary to translation. As
expected eIF4E mRNA levels were increased by approximately
16-fold (Table S1).
Next, we identified the mRNAs that sedimented with the
polysomal fractions from induced 3T3-tTA and 3T3-tTA-eIF4E
cell lines and normalized them against total RNA (Fig. 1D). This
allowed for the scoring of an increase in translational efficiency of
a mRNA independent of its abundance in the cell. We then
identified those genes whose polysomal/total RNA level differed
between 3T3-tTA and 3T3-tTA-eIF4E cells. A preliminary
analysis was conducted using a cutoff ratio of 1.5 (Table S2).
Further statistical analysis was undertaken (described in Materials
& Methods section) and results are shown in Table S3. eIF4E
induction resulted in a shift of 294 mRNAs (unique and annotated)
to the heavier polysome fractions (Table S3). To search for
biological themes that are associated with genes whose translation
is affected by eIF4E, we looked for overrepresentation of genes
belonging to groups classified by the gene ontology consortium
[30]. We separated the dataset into two parts, mRNAs whose
translation is activated and mRNAs whose translation is repressed.
We considered those that showed a .2-fold relative enrichment
and a ,0.05 Fisher’s test p-value significant. Several functional
categories were enriched among genes that were translationally
activated including: protein biosynthesis, members of the small and
large ribosomal subunits and mitosis related proteins (Table S4).
The recruitment of 245 of mRNAs to ribosomes was decreased
(Table S3). The translationally repressed mRNAs were more
diverse than the stimulated mRNAs including categories related to
differentiation and cell migration (Table S5). While we expected
activation of translation as a function of eIF4E induction, the large
number of genes whose translation was repressed after eIF4E
induction is surprising. Mechanisms that can modulate trans-
lational activity of subsets of transcripts exist e.g. micro RNAs
(miRNA), which target transcripts for translational silencing [31–
33]. We hypothesized that miRNA mediated repression, as
a possible eIF4E compensatory mechanism, could account for
some of the translational repression and searched for over-
representation of miRNA target sequences among the translation-
ally repressed genes [34]. Interestingly, we found an enrichment of
genes with target sites for several miRNAs (14 different miRNAs,
Table S5). A similar search among translationally activated
transcripts yielded enrichment of only one miRNA (Table S4).
This suggests that compensatory miRNA-mediated translational
repression might explain a part of the genes that were identified as
translationally repressed. Furthermore, untranslated small RNAs/
miRNAs have recently been shown to affect the rate-limiting steps
of translation initiation [35,36].
Among the different classes of mRNAs that were recruited to
ribosomes, the most unexpected was that ribosomal protein
mRNAs from both the small and large subunits (Table S3, Table
S4). It is striking, however, that not all ribosomal protein mRNAs
were recruited: 26 out of 63 ribosomal protein mRNAs as well as 2
out 13 mitochondrial ribosomal protein mRNAs on the array were
recruited to polysomes. Importantly, the sedimentation of growth-
related mRNAs was also shifted to heavier polysomes: these
include mRNAs encoding anti-apoptotic proteins; growth factors;
various cell signaling proteins (kinases, phosphatases); transcription
factors and proteins involved in growth and proliferation, mRNA
processing, protein degradation and modification, cellular de-
toxification and transport (Table S3).
eIF4E overexpression stimulates the translation of
a subset of mRNAs
To demonstrate that the eIF4E-induced recruitment of mRNAs to
polysomes results in enhanced protein levels, several of the
proteins of the newly-identified targets were analyzed by Western
blotting. The selection of mRNAs was based on the analysis
presented above as well as a preliminary analysis of translational
activation (Tables S2 and S3). Most genes found in the preliminary
analysis were also identified in the final analysis. Some genes failed
to pass the more stringent threshold in the final analysis, yet
exhibited the translational activation that was predicted, showing
that false negatives occur in the present final analysis. To further
corroborate our results, NIH 3T3 cells and primary mouse
embryonic fibroblasts (MEFs) that constitutively express hemag-
glutinin-tagged eIF4E (HA-eIF4E) were examined in parallel to
the inducible cell line (Fig. 2A and B). HA-eIF4E was detected in
the stable cell lines (Fig. 2A, lanes 12 and 14) and was expressed at
,50% of the level of endogenous eIF4E, assuming that the anti-
eIF4E antibody reacts with the HA-tagged protein with an affinity
similar to that of eIF4E. We chose to study the levels of several
representative eIF4E targets because of the anti-apoptotic and
proliferative activities of eIF4E: three anti-apoptotic proteins, bax-
inhibitor 1 (BI-1), defender against cell death 1 (dad1) and
survivin; the mitosis-related factor centromere autoantigen A
(cenpA); the growth- and angiogenic-factor macrophage migration
inhibitory factor (MIF) and ribosomal proteins. eIF4E over-
expression led to a significant increase (2- to 4-fold) in the amounts
of BI-1, dad1, survivin, cenpA and MIF proteins in both the
inducible and constitutive cell lines (Fig. 2A). Overexpression of
eIF4E also caused a significant increase in the amount of a subset
of ribosomal proteins from both ribosomal subunits (Fig. 2A,
compare lanes 7–10 to 6). In accordance with these data, increased
levels of the ribosomal proteins were also observed in the NIH 3T3
cells and MEFs that constitutively express HA-eIF4E (lanes 12 and
14). To control for specificity, the expression of other translation
factors (eIF4GI and eIF4AI), components of the PI3K/Akt/
mTOR signaling pathway (TSC2, raptor and the translational
repressor 4E-BP1) and b-actin was also determined. No changes in
their protein levels were observed in eIF4E-expressing cells
(Fig. 2B). Importantly, the levels of ribosomal proteins whose
mRNAs did not shift in the polysome gradients (S6, L7a and L9)
also failed to increase in response to eIF4E induction (Fig. 2B,
lanes 7–10, 12 and 14). These data demonstrate that eIF4E
specifically increases the translation of a subset of mRNAs.
eIF4E induction could in principle either facilitate the re-
cruitment of mRNA to ribosomes or affect protein stability. To
distinguish between these two possibilities, RT-PCR was per-
formed on total RNA and polysomal fractions from uninduced
and induced 3T3-tTA-eIF4E cells. mRNA levels of two anti-
apoptotic proteins (BI-1, survivin), the growth-related factor MIF,
a subset of ribosomal proteins (L23, L34, L9, S17) and b-actin
were examined. No changes in total mRNA levels were detected
after induction (Fig. 3A, last two lanes). Next, the mRNA
distribution along the sucrose density gradient was studied. The
mRNAs for BI-1, survivin and MIF all shifted to the heavier
polysome fractions in the eIF4E-overexpressing cells (Fig. 3A).
eIF4E induction also led to increased association of the ribosomal
protein mRNAs L23 and L34 with the heavier polysome fractions
(Fig. 3A). Two other ribosomal protein mRNAs (L9 and S17)
failed to shift to heavier polysomes after eIF4E induction (Fig. 3A).
We did not observe changes in b-actin mRNA distribution along
the gradient between induced and uninduced cells (Fig. 3A). To
ensure that the RT-PCR assay is a valid assay for measuring
eIF4E in Cell Transformation
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actin mRNA distribution was also determined by Northern
blotting. In agreement with the RT-PCR data, the L34 mRNA
shifted to heavier polysome fractions in the eIF4E-overexpressing
cells (Fig. 3B). No change in b-actin mRNA distribution was
observed (Fig. 3B). Thus, eIF4E overexpression facilitates the
recruitment of a subset of mRNAs to polysomes.
eIF4E knockdown leads to decreased expression of
eIF4E target proteins
To further ensure that the above described effects are a direct
consequence of eIF4E induction, we used small interfering RNA
(siRNA)-mediated knockdown of eIF4E to show that the novel
targets were affected by eIF4E depletion. An siRNA against
murine eIF4E was transiently transfected into NIH 3T3 cells.
Another siRNA, 4E-T-inv, which corresponds to a scrambled
sequence of the human 4E-transporter protein (4E-T; [37]) and
which has no homology to any murine EST or cDNA, was used as
a control. Transient transfection of the eIF4E siRNA resulted in
a decrease (2- to 3-fold) in eIF4E protein levels relative to the
mock-transfected and to the 4E-T-inv siRNA–transfected cells
(Fig. 4, compare lanes 1 and 2 to 3). eIF4E knockdown caused
a significant decrease (,4 to 6-fold) in the levels of dad1, survivin,
cenpA and MIF protein, which is consistent with our finding that
eIF4E overexpression causes their increased expression (compare
lanes 1 and 2 to lane 3). The level of ODC, a known target of
eIF4E [38,39], was also significantly reduced (,4-fold) in eIF4E
siRNA transfected cells (Fig. 4). Knockdown of eIF4E also resulted
in a decrease of L13, L23, L26, L29, L32, L34, L35 and L39
protein levels (2- to ,8-fold; Fig. 4). As expected, no changes in
the expression of eIF4GI, eIF4AI, raptor, TSC2, 4E-BP1 and b-
actin proteins were observed (Fig. 4, lanes 4–6). Furthermore, no
decrease in L5, L7a or S6 proteins was seen in these cells (Fig. 4,
lanes 4–6). These results confirm that eIF4E preferentially
stimulates the translation of a subset of mRNA targets. Our
results are summarized in Table S6.
eIF4E and apoptosis
eIF4E protects cells against apoptosis [40]. The identification of
novel anti-apoptotic eIF4E targets such as BI-1 [41], dad1 [42]
and survivin [43] could explain the anti-apoptotic activity of
eIF4E. It was therefore pertinent to show that induction of
eIF4E protects cells against apoptosis. As previously shown [40],
constitutive expression of HA-eIF4E protected cells against
ionomycin-induced apoptosis (24 hr: 23% vs. 11% apoptotic;
Fig. 5A). The protective effect of eIF4E was even more striking in
the eIF4E-inducible cell line because it expresses more eIF4E than
does the constitutively expressing HA-eIF4E cell line: eIF4E
overexpression in the induced 3T3-tTA-eIF4E cells resulted in
a substantial decrease in ionomycin-induced apoptosis (24 hr: 33%
vs. 12%; Fig. 5B). No difference was detected in the 3T3-tTA
parental cell line (Fig. 5B). eIF4E overexpression also prevented
the activation of pro-caspase 12 and pro-caspase 3. When 3T3-
tTA and 3T3-tTA-eIF4E cells were induced for 16 hr and then
treated with ionomycin, pro-caspase 12 and pro-caspase 3 cleavage
to generate their active forms was not observed in induced 3T3-
tTA-eIF4E cells. In comparison, pro-caspase cleavage was easily
detected in induced 3T3-tTA and uninduced 3T3-tTA-eIF4E cells
(Fig. 5C, compare lane 6 to lanes 2 and 4, respectively).
eIF4E and ribosomal protein mRNA translation
The mechanism by which only a subset of mRNAs are selectively
translated upon over expression of eIF4E is not immediately clear.
The simplest mechanism would be that features in the UTRs
determine which transcripts are selected for translational activa-
tion when eIF4E is increased [23]. To test whether any known
Figure 2. eIF4E induction stimulates the translation of a subset of mRNAs. A) Western blotting of extracts from 3T3-tTA versus 3T3-tTA-eIF4E cells
after eIF4E induction (0 to 24 hr) and from NIH 3T3 cells and MEFs that constitutively express HA-eIF4E or vector alone. eIF4E induction was
determined by using anti-HA and anti-eIF4E antibodies. Fold increase at the 24 hr time point was determined using NIH Image. B) Western blotting
experiments were performed as described in (A). These experiments were repeated three times using three different sets of whole-cell extracts.
doi:10.1371/journal.pone.0000242.g002
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PLoS ONE | www.plosone.org 4 February 2007 | Issue 2 | e242Figure 3. eIF4E induction causes an increase in the recruitment of a subset of mRNAs to polysomes. A) Total and polysomal (24 fractions) RNA
from induced (2tet for 5 hr) and uninduced (+tet for 5 hr) 3T3-tTA-eIF4E cells was reverse transcribed into cDNA. Primers for BI-1, survivin, MIF, L23,
L34, L9, S17 and actin were used to assess mRNA levels. Amplified PCR bands from the polysomal fractions were quantified using NIH Image, and
absolute values were plotted. B) The effect of eIF4E induction on L34 mRNA distribution was assessed by northern blotting. Polysomal RNA was
isolated from induced (2tet for 5 hr) and uninduced (+tet for 5 hr) 3T3-tTA-eIF4E cells and fractionated into 12 fractions (for purpose of detection).
The RNA was loaded on an agarose denaturing gel and transferred to a nitrocellulose membrane. Membranes were probed with radiolabeled murine
L34 and actin probes. Bands were quantified using NIH Image, and absolute values were plotted.
doi:10.1371/journal.pone.0000242.g003
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ally activated, we used the annotation provided by the UTRsite
[44]. All elements that showed a .2-fold enrichment and a Fisher’s
test p-value,0.05 were considered significant. Two known
elements were enriched among transcripts that were translation-
ally activated: 59-TOP (59-terminal oligopyrimidine) and Mos-
PRE (Mos polyadenylation response element) (Table S4).
The TOP sequence is present at the 59 end of all mammalian
ribosomal protein mRNAs and several translation factor mRNAs,
and plays a critical role in their translational regulation [reviewed
in 45,46]. An interesting possibility is that only a subset of TOP
sequences confers differential eIF4E responsiveness. We therefore
examined the effect of eIF4E induction on a TOP-responsive
luciferase reporter: DNA segments containing the promoters and
59 UTRs of murine ribosomal proteins L32, L32 mut (non-TOP),
S16, S16 mut (non-TOP), L30 and b-actin (non-TOP) were
subcloned upstream of the luciferase gene. Only the L32
ribosomal protein mRNA is an eIF4E target. 3T3-tTA and 3T3-
tTA-eIF4E cells were transfected with the various luciferase
reporters and induced for 16 hr. Induction of eIF4E led to
increased activity of only the TOP-containing L32 59 UTR
reporter (2- to 3-fold; Fig. 6A). Strikingly, mutating the TOP
sequence in the L32 59 UTR abrogated its responsiveness to eIF4E
(Fig 6A). eIF4E overexpression did not affect the activity of the
mRNAs which contain sequences that do not respond to eIF4E:
L30, S16, S16 non-TOP mutant or the b-actin 59 UTR–
containing reporters (Fig. 6A). Luciferase activity of the reporters
was also investigated in the parental cell line 3T3-tTA. No
increase in activity was detected in these cells (Fig. 6B).
Next, we wished to determine whether the L32 TOP element
alone could confer responsiveness to eIF4E independently of the
downstream 59UTR sequence. To this end, the S16 and L30
TOPs were exchanged for the L32 TOP (Fig. 6C). Significantly,
eIF4E induction led to increased luciferase activity (2- to 3-fold) of
both the mutated S16 and L30 59 UTRs, which now possessed the
L32 TOP sequence (Fig. 6D). The TOP sequence of S16 and L30
was also introduced into the L32 59 UTR (Fig. 6C). Consistent
with the earlier results, the exchange of the L32 TOP for that of
S16 and L30 (L32 to S16 and L32 to L30) rendered these mRNAs
unresponsive to eIF4E (Fig. 6D). Luciferase activity was also
investigated in the parental cell line 3T3-tTA. No increased
activity was observed in these cells (Fig. 6E). Taken together, these
results clearly demonstrate that eIF4E overexpression affects only
a subset of TOP-containing mRNAs.
DISCUSSION
eIF4E is thought to stimulate the translation of a subset of mRNAs
whose 59 UTRs contain extensive secondary structure [23]. A
prevailing model postulates that eIF4E functions as part of the
eIF4F complex to melt the 59 mRNA secondary structure to
facilitate ribosome binding and scanning [7]. Because eIF4E is the
limiting factor for eIF4F assembly, it determines the availability of
eIF4F for unwinding of mRNA secondary structures [20,21].
Through the use of microarray analysis of polysome fractions, we
identified novel eIF4E targets that are involved in ribosome
biogenesis, cell proliferation and survival. Many of these mRNAs
are predicted to contain extensive secondary structure (e.g., BI-1,
dad1, survivin, cenpA and MIF). We also identified mRNA targets
that are not predicted to contain extensive 59 secondary structure,
partly because the search for targets was biased against such
mRNAs. Two earlier studies suggested that eIF4E could stimulate
ribosomal protein mRNA translation both in vivo and in vitro
[47,48]. Our study shows the importance of eIF4E in the
translational regulation of a subset of ribosomal protein mRNAs.
A large body of evidence is consistent with the notion that
synthesis of ribosomal proteins is required for cell growth,
proliferation and survival [46,49–51]. Increased ribosomal protein
and rRNA synthesis promote the assembly of ribosomes and
subsequently affect the rate of protein synthesis. Many types of
cancers exhibit elevated amounts of ribosomal proteins [49,52–
55]. They also often exhibit higher rates of protein synthesis
activity that are proportionate to their increased growth and
proliferation [49].
Several of the ribosomal proteins identified here as targets of
eIF4E are upregulated in different cancers. For example, S13 and
L23 are upregulated in multi-drug-resistant gastric cancers and
promote multi-drug resistance by suppressing apoptosis [56]. L32
expression correlates with the progression of human prostate
cancer [57], and S27 is overexpressed in melanomas [58]. In this
report, we show that eIF4E overexpression affects the translation
of only a subset of TOP mRNAs. Thus, one possibility is that some
of the functions of ribosomal proteins in control of cell growth,
proliferation, differentiation and survival are extra-ribosomal
[49,59]. This is consistent with a lack of increase in rRNA levels
or differential rRNA processing in the eIF4E-overexpressing cells
(unpublished observations).
Rapamycin inhibits mTOR activity and consequently di-
minishes eIF4E function [60]. Grolleau et al. identified mRNAs
whose translation is suppressed by rapamycin treatment of Jurkat
T cells [61]. Many of the mRNAs whose association with
Figure 4. siRNA mediated knockdown of eIF4E in NIH 3T3 cells. NIH
3T3 cells were transiently transfected with an siRNA against murine
eIF4E or with a control siRNA, 4E-T-inv (scrambled sequence of human
4E-T), for 48 hr. Cells were lysed, and protein extracts were subjected to
SDS-PAGE, followed by western blot analysis. The RNAi-mediated
knockdown was repeated three times.
doi:10.1371/journal.pone.0000242.g004
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such as survivin, dad1, ribosomal proteins S7, S9, S13, S21, S24,
S26, S27, L13, L23, L29, L32, L34 and L35, proteasome subunit
b type 1 and type 3, protein tyrosine phosphatase 4A2, cyclophilin
A, glutathione-S-transferase and the ATPase synthase subunit C.
Another study has also shown that TOR inhibition in yeast leads
to a significant decrease in the translation of mRNAs encoding
initiation factors and ribosomal proteins [62]. These results are
important in establishing a direct link between the tumorigenic
properties of components of the PI3K/Akt/mTOR pathway and
translation initiation via eIF4E. mTOR phosphorylates directly or
indirectly several translation factors including 4E-BPs, S6Ks,
eIF4G, eIF4B and eEF2 [reviewed in 63,64,65]. Because inhibi-
tion of mTOR by rapamycin results in a reduction of similar set of
mRNAs whose translation is also stimulated by eIF4E [61], it can
be concluded that mTOR stimulates translation via its phosphor-
ylation of the eIF4E repressors, the 4E-BPs. Thus, eIF4E is an
important target of the PI3K/Akt/mTOR pathway that mediates
its wide-ranging cellular activities [63,65–67].
A recent study that was published after this paper was
completed also identified targets of eIF4E [25]. However, this
study used stably eIF4E-expressing NIH 3T3 cell line. Thus, it is
likely that some of the results published by Larsson et al. are due to
secondary effects of eIF4E overexpression. We used a relaxed
significance threshold (q,20%, as defined in SAM) as previously
described [25], to identify genes that are differentially translated in
each study and then identified the overlap. This approach resulted
in identification of 340 cDNA clones representing 214 unique
Figure 5. eIF4E induction protects cells against ER-mediated apoptosis. A) 3T3 cells that stably express HA-eIF4E were treated with 5 mM
ionomycin for different periods, fixed and stained with propidium iodide. The percentage of apoptosis was quantified by flow cytometry (triplicates
were pooled to generate the s.d.) B) 3T3-tTA and 3T3-tTA-eIF4E cells were seeded at 75% confluency and cultured for 8 hr. Tetracycline containing
medium was then replaced by a tetracycline free medium for 16 hr to induce eIF4E expression. Uninduced cells were cultured for the same period
without removal of tetracycline. Cells were treated with ionomycin and processed as described in (A). C) 3T3-tTA and 3T3-tTA-eIF4E cells were seeded
and cultured with or without tetracycline as described in (B). Cells were then cultured for 24 hr in complete medium65 mM ionomycin. Protein
extracts were resolved by SDS-PAGE and transferred to membranes, which were immunoblotted with anti–caspase 3 and anti–caspase 12. eIF4E
expression was also examined by immunoblot; elevated eIF4E levels were only detected in 3T3-tTA-eIF4E induced cells (2tet).
doi:10.1371/journal.pone.0000242.g005
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proteins. The lack of a larger overlap is most likely due to
a combination of biological and technical issues. The biological
differences include the model system, a short period of eIF4E
induction in the present study and the possible secondary
consequences of constant eIF4E expression in the previous report.
Technical differences include the definition of the translationally
active pool, study design, differences in protocols used for
microarray labeling and hybridization and usage of a cDNA
platform that has been shown to show higher variability in a high
proportion of cases (although it is beyond the scope of this study to
define the performance of the platform across labs, chip-versions
and batches) [68].
This study identified novel anti-apoptotic eIF4E targets,
including survivin, which has a well-documented role in cancer
cell growth and cell survival [43]. Survivin is highly expressed in
several cancers, and its expression is sensitive to PI3K/Akt/
mTOR inhibitors [69,70]. CenpA, dad1, BI-1 and MIF are also
overexpressed in human cancers [71–75]. eIF4E-mediated expres-
sion of these proteins would therefore significantly increase cellular
proliferation and inhibit apoptosis. In summary, overexpression of
eIF4E preferentially stimulates the translation of a subset of
mRNAs that encode small- and large-subunit ribosomal proteins,
anti-apoptotic proteins and cell growth–related factors. Decipher-
ing how the translational machinery preferentially translates these
mRNAs will lead to a better understanding of the proteome’s
regulation and its involvement in diseases such as cancer.
MATERIALS AND METHODS
Generation of eIF4E-overexpressing cell lines
The eIF4E-inducible NIH 3T3 (3T3-tTA-eIF4E- TET OFF
system) cell line was previously described [27]. The 3T3-tTA
parental cell line was used as control. The cell line that stably
overexpresses eIF4E was generated using the pBabe retroviral
system (Clontech). The packaging cell line Phoenix Ecotropic
(transformed human embryonic kidney cells) was cultured in
DMEM with 10% FBS. The packaging cell line was transfected as
described by Dr. G. Nolan’s protocols (www.stanford.edu/group/
nolan/phx_helper_free.html) with two vectors: pBabewt (no insert)
and pBabe-HA-eIF4E (3 HA tags). Virus was harvested from the
packaging cell line 48 hr after transfection and was used to infect
NIH 3T3 cells and MEFs. Cells were infected twice (every 24 hr)
in the presence of 8 mg/ml polybrene (Sigma). Transduced NIH
3T3 cells were subjected to drug selection (2 mg/ml puromycin,
final concentration) 48 hr after infection. A polyclonal population
resistant to puromycin was used for analysis of protein expression.
Primary MEFs (passage 4) were used to generate the HA-eIF4E-
Figure 6. eIF4E and TOP mRNA translation. A) DNA segments encompassing the promoters and 59 UTRs of L32, L32 mut (non-TOP), S16, S16 mut
(non-TOP), L30 and b-actin were subcloned upstream of the firefly luciferase gene. 3T3-tTA-eIF4E cells were transfected with the various firefly
luciferase reporters and a renilla luciferase reporter, which was used for transfection efficiency, and were cultured for 32 hr. Tetracycline containing
medium was then replaced by a tetracycline free medium for 16 hr; control (non-induced) cells were cultured in parallel with tetracycline. Firefly
luciferase activity (FLU) was measured and normalized against renilla luciferase activity (RLU). B) Luciferase activity of the reporters was measured in
the parental cell line 3T3-tTA as described in (A). C) TOP sequences of L32, S16 and L30 are depicted. The arrows indicate the transcriptional start site.
The nucleotide changes between L32 and S16 and L32 and L30 are underlined. D) Mutated reporters were generated by exchanging the TOP
sequences of L32, S16 and L30. Luciferase assays were performed as described in (A). E) Luciferase activity of the reporters was measured in the
parental cell line 3T3-tTA as described in (A). Assays were carried out in triplicate. Luciferase activities represent an average obtained from three
independent experiments.
doi:10.1371/journal.pone.0000242.g006
eIF4E in Cell Transformation
PLoS ONE | www.plosone.org 8 February 2007 | Issue 2 | e242expressing MEFs as described above. Selection of MEFs was
performed for 3 days. A polyclonal population resistant to
puromycin was used for analysis of protein expression. Cells were
lysed in 40 mM HEPES-KOH [pH 7.5], 120 mM NaCl, 1 mM
EDTA, 10 mM pyrophosphate, 10 mM glycerophosphate,
50 mM NaF, 1.5 mM Na3VO4, 0.3% CHAPS and one tablet
EDTA-free protease inhibitors (Roche) for 10 min on ice. Protein
supernatants were recovered after a 10-min spin at 14,000 g.
Protein concentration was determined using the Bradford reagent
(BioRad). Protein extracts were subjected to SDS-PAGE and
transferred to a nitrocellulose membrane, which was probed with
various antibodies as described below.
Sucrose gradient fractionation and polysome
isolation
3T3-tTA-eIF4E and 3T3-tTA cells were grown in 150-mm dishes
to 80% confluency. eIF4E expression was induced by removing
tetracycline from the medium for 5 hr; cells were then treated with
cycloheximide (100 mg/ml) for 15 min at 37uC. Cells were washed
three times in cold PBS containing 100 mg/ml cycloheximide and
were scraped off the plate using a rubber policeman and 1 ml of
the same solution. Cells were centrifuged for 5 min at 1,000 rpm
and resuspended in 850 ml hypotonic lysis buffer (5 mM Tris-HCl,
pH7.5; 2.5 mM MgCl2; 1.5 mM KCl). Cells were transferred to
a pre-chilled tube and incubated with 100 mg/ml cycloheximide,
2 mM DTT and 2 ml RNAsin Inhibitor (40 U/ml; Stratagene).
Cells were incubated on ice for 5 min and vortexed. To each
850 ml of cells, 50 ml of 10% Triton X-100 and 50 ml of 10%
sodium deoxycholate were added; cells were then vortexed and
incubated on ice for 5 min. Cell extracts were centrifuged for
5 min at 14,000 rpm; the supernatants were collected and loaded
onto a pre-chilled 10–50% sucrose gradient. Each gradient was
formed by mixing 5.5 ml of 10% and 50% sucrose in a Beckman
Centrifuge tube (14689 mm; Beckman Instruments #3311372,
CA, USA) using a Labconco pump (Kansas City, MO, USA).
Gradients were placed in a Beckman SW40Ti rotor and centri-
fuged at 35,000 rpm for 2 hr at 4uC. Fractions were collected (24
fractions of 12 drops each) using a Foxy JR ISCO collector and
UV optical unit type 11 (St-Lincoln, NE, USA).
RNA isolation for microarrays
Total RNA was isolated using Trizol as described by the
manufacturer (Invitrogen). RNA from sucrose gradients was
isolated by using Trizol at a 1:1 ratio (500 ml of fraction and
500 ml of Trizol). The last seven fractions (#18–24; heavy
polysomes) were pooled, extracted with phenol-chloroform,
ethanol precipitated and used for microarray analysis. RNA
purity and integrity were assessed by spectrophotometric analysis
(OD 260/280) and denaturing agarose gel.
Microarray analysis
Total or polysomal RNA (10 mg) was used for microarrays.
Microarrays were performed using a direct labeling protocol
according to the UHN Microarrray Centre (Toronto, Canada,
http://www.microarrays.ca/support/proto.html). Mouse 15K3
cDNA arrays were purchased from the UHN Microarrray Centre;
they were scanned and the resulting images were digitalized using
Axon GenePix 4000B scanner and software. Preliminary analysis
was conducted using Iobion software (lowess approach) with
a cutoff ratio of 1.5. The data from the final analysis was
normalized using the bioconductor [76] library ‘‘limma’’ [77] and
the non-print tip lowess approach without background subtraction
[78] as this increases the accuracy of the obtained measurements
[68]. Replicate spots on each array were separated and treated as
independent. After normalization we identified structural variation
from both dye bias and experimental set using principal
components analysis (PCA, data not shown). We therefore used
a paired analysis where samples were stratified based on dye and
experimental set. This pairing did not introduce any bias in the
analysis regarding these sources of structural variation. After
pairing the biological theme, where the estimates from trans-
lational efficiency from two cell lines could be separated, was
apparent in PCA components describing a large proportion of the
total data set variation (data not shown). This indicates that the
data analysis approach is valid.
Significant differentially expressed/translated genes were iden-
tified using the Significance Analysis of Microarrays (SAM)
algorithm using a q-value threshold of q,0.1 [79]. SAM was
performed in R (r-project.org) using the library (‘‘samr’’) and
a ‘‘Two class paired’’ analysis. No data filtering was performed
before SAM as described [80]. mRNAs whose polysomal/total
were changed by at least 1.3-fold (q-value,0.1) between the
eIF4E-overexpressing cell line and the parental cell line were
considered significant. As we initially identified an over-represen-
tation of ribosomal genes and these tend to be highly expressed,
which reduces the dynamic range of their fold changes, we used
a relatively modest fold change criteria (1.3) in combination to our
statistical threshold (q,0.1). The dataset has been submitted to
GEO accession number GSE6639, including raw data files to
enable future integrative analysis [81].
We used the Perl module GO: Termfinder [82] to assess over-
representation of functional terms as defined by the gene ontology
consortium [83], known RNA elements [44] and miRNAs [34],
targetscan v3.0) among genes that were identified to be transla-
tionally regulated. The analysis was stratified into two parts
assessing overrepresentation among genes that were translationally
activated and translationally repressed. For this analysis, no fold
change filtering was performed.
Experimental design
All microarray comparisons were performed in quadruplicates
using dye swaps performed on the same RNA extraction (thus 4
arrays were used per sample class derived from two separate RNA
extractions).
For changes at the transcriptional level, total RNAs from the
3T3-tTA and 3T3-tTA-eIF4E cell lines were compared. Micro-
array experiments were performed on total RNA from uninduced
(+tet for 5 hr) versus induced (2tet for 5 hr) 3T3-tTA cells, and
the obtained ratios were compared to the ratios of total RNA from
uninduced (+tet for 5 hr) versus induced (2tet for 5 hr) 3T3-tTA-
eIF4E cells using the paired analysis described above.
For changes at the level of translation, total RNA was compared
to heavy polysomal RNA from both 3T3-tTA and 3T3-tTA-eIF4E
induced (2tet 5 hr) cell lines. Changes in the ratio between
polysomal vs total RNA levels between 3T3-tTA and 3T3-tTA-
eIF4E induced cells were identified using the paired analysis
described above.
Western blot analysis
Whole-cell extracts (NIH 3T3, 35–50 mg protein; MEFs, 125–
250 mg) were resolved on a 4–20% gradient SDS-PAGE and
transferred to a nitrocellulose membrane (BioRad). The mem-
brane was blocked in 5% milk/16 PBS for 1 hr and probed
overnight at 4uC with the appropriate antibody. The signal was
detected with secondary antibodies conjugated to horseradish
peroxidase at a dilution of 1:1,000 and developed with
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chased or received from the following sources: a-eIF4E (BD
Biosciences); a-dad1 (A. Winoto, University of California, Berkley,
CA, USA); a-cenpA (W. Lee, Murdoch Children’s Research
Institute, Parkville Victoria, Australia); a-MIF (T. Roger, In-
fectious Diseases Service CHUV, Lausanne, Switzerland); a-Bax-
inhibitor-1 (MBL International); a-survivin (Novus Biologicals);
a-L13, -L29, -L32, -L34, -L35 and -L39 (described previously in
[84]; a-L26 (M. Kastan, St. Jude Children’s Research Hospital,
Memphis, TN, USA); a-L5 and a-L23 (H. Lu, Oregon Health &
Sciences University, OR, USA.); a-L7a (S. Fumagalli, University
of Cincinnati, OH, USA); a-L9 (Transduction Laboratories);
a-eIF4GI N-terminal [85]; a-eIF4AI [86]; a-raptor (unpublished
data); a-S6 and a-4E-BP1 (Cell Signaling Technology); a-TSC2
(Santa Cruz) and a-actin (Sigma).
RT-PCR assays
RT-PCR was performed with the BD Biosciences RT-PCR kit
(K1402-2). For the reverse transcription reaction, 1 mg of total
RNA and 1 ml of each polysome fraction were used. The diluted
cDNA (2 ml from a 1 in 100 dilution) was used in a 20 ml PCR
reaction with Precision TaqPlus (Stratagene). Aliquots were loaded
on a 1.5% agarose gel and visualized by ethidium bromide stain-
ing and UV shadowing. A 540 bp actin fragment was amplified
using the mouse b-actin control amplimer set (BD Biosciences,
#5408-1). All other cDNAs were amplified by PCR primers
purchased from Invitrogen (all noted 59-39): BI-1-59, GCCAG-
TTTTGCACTATGTATG; BI-1-39, AGAGAGGACAGGAG-
CATGAG; Survivin 59, CAGATCTGGCAGCTGTACCT; Sur-
vivin 39, GGCTCTCTGTCTGTCCAGTT; MIF-59, CTTAT-
GTTCATCGTGAACACC; MIF-39, GCGTTCATGTCGTAA-
TAGTTGA; L23-59, AGGACGCGGTGGGTCCTC; L23-39,
GCGTTGGATGCAATTCTGGG; L34-59, ATGGTCCAGCG-
TTTGACATAC; L34-39, ACTCTGTGCTTGTGCCTTCAA;
L9-59, AACATGATCAAGGGTGTCACG; L9-39, GATGCCG-
TCCAAAAACTTCCT; S17-59, TCATCGAGAAGTACTACA-
CGC and S17-39, CTGAGTGACCTGAAGGTTAG. Increasing
PCR cycles (18–33) and cDNA from total RNA were used to
determine the number of cycles needed for amplification in the
linear range for each transcript. The linear range was determined
to be 23 cycles for b-actin and 28 cycles for MIF, survivin, L23,
L34, L9 and S17. RT-PCR quantification was performed using
NIH Image software.
Northern blot analysis
3T3-tTA-eIF4E cells from five 150-mm plates (70–80% con-
fluency) that were induced by removing tetracycline from the
medium (2tet for 5 hr) or that were uninduced (+tet for 5 hr) were
collected, lysed and fractionated by sucrose gradient ultracentri-
fugation (as described above). RNA was fractionated into 12
fractions unlike for RT-PCR assays (24 fractions) for purpose of
detection. The fractions were extracted using Trizol (as described
above). RNA fractions were heated at 70uC for 10 min in RNA
sample buffer, rapidly cooled on ice and loaded on a MOPS-
formaldehyde agarose gel (Northern Max Kit, Ambion). RNAs
were separated at 85 V, and visualized by UV shadowing. RNA
was transferred to a BrightStar Plus membrane (Ambion) and
crosslinked to the membrane by UV irradiation. cDNA fragments
from L34 and actin were generated by PCR (refer to primers
described above for RT-PCR). Denatured cDNAs were labeled
using the Ready-to-Go DNA labeling kit (Amersham) in the
presence of [a-
32P]dCTP. Unincorporated dCTP was removed
using micro Spin S-200 HR columns (Amersham). Membranes
were prehybridized for 30 min at 42uC with hybridization solution
(Northern Max Kit). Membranes were then incubated with
1610
6 cpm/ml of radiolabeled probe in hybridization solution
overnight at 42uC. Membranes were washed as described in the
manual (Northern Max Kit) and exposed to film.
RNAi
siRNA against eIF4E was designed by Dharmacon software. Cells
were seeded in 6-well plates at 20% confluency and transfected the
next day using Lipofectamine Plus reagent (Invitrogen). On the
day of transfection, cells were washed twice and incubated with
750 ml of OptiMem (Invitrogen) per well. The transfection pro-
tocol was as follows: in a polystrene tube (for one 6-well plate),
645 ml of OptiMem was added to 45 mlo f4 0mM eIF4E or 4E-T
inverted control siRNA (Dharmacon) and 60 ml of PLUS reagent
(Invitrogen) and this mixture was incubated 15 min at room
temperature. A mixture of OptiMem (690 ml) and Lipofectamine
reagent (60 ml) (Invitrogen) was added and further incubated for
15 min at room temperature. Each well received 250 ml of the
combined mixture, and the plates were incubated for 3 hr at 37uC.
The transfection mixture was removed and replaced with
complete medium. Cells from each 6-well plate were trypsinized
and seeded onto one 150-mm plate 24 hr after transfection. Cells
were harvested for western blotting and polysome fractionation
48 hr after transfection.
Apoptosis assays
NIH3T3 cells that stably overexpress HA-eIF4E were cultured in
100-mm dishes at 75% confluency in complete medium with or
without 5 mM of ionomycin (Sigma). The eIF4E-inducible cells, as
well as the parental cells, were seeded in 100-mm dishes at 75%
confluency and cultured for 8 hr, at which point tetracycline was
removed from the medium to induce eIF4E for 16 hr. On the next
day, both the inducible and parental cells were treated with 5 mM
of ionomycin for 4, 8, 16 or 24 hr. All cells were fixed in 70%
ethanol, stained with propidium iodide (50 mg/ml) and treated
with RNAse A (20 mg/ml) in 16 PBS/5 mM EDTA for 1 hr at
room temperature. The percentage of apoptosis was quantified by
flow cytometry. For caspase 3 and caspase 12 immunoblots, cells
were seeded in 150-mm dishes at 75% confluency and cultured for
8 hr. Cells were treated with a tetracycline free medium to induce
eIF4E for 16 hr, after which the cells were cultured for 24 hr in
complete medium with or without 5 mM of ionomycin. Cells were
lysed as described above. Protein extracts (100 mg) were subjected
to SDS-PAGE and immunoblotted with anti–caspase 3 and anti–
caspase 12 antibodies (Cell Signaling Technology).
Constructs
The plasmids for 59 UTRs of murine b-actin, L32, L32 mut (non-
TOP; C-A mut), S16, S16 mut (non-TOP) and L30 were provided
by O. Meyuhas (Hebrew University, Jerusalem, Israel). DNA was
PCR-amplified with PWO polymerase (Stratagene) and subcloned
into the pGL3 basic-luciferase reporter (Promega). Primer se-
quences (including restriction enzymes sites, which are underlined)
are as follows (all noted 59-39): 59L32 and actin, ACGTACGCGT-
CGACGGCCAGTGCCAAG; 39L32, ACGTAGATCTTTGG-
GATCCG GCAGCCAC; 39actin, ACGTAGATCTTTGGGAT-
CCTCTAGAGTCG; 59S16wt and mut, ACGTACGCGTAAG-
CTTGCATGCACAGCT; 39S16wt, ACGTCTCGAGGGATC-
CTCTAGCCACACC; 39S16mut, ACGTCTCGAGGGATCC-
CCACACCGCAG; 59L30wt, ACGTACGCGTAAGCTTCAG-
AACAAACGCC and 39L30wt, ACGT CTCGAGGGATCCTC-
TAGCCAGCCG. Constructs were verified by restriction enzyme
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CTAGCAAAATAGGCTG TCCCC, and reverse, TTTATGT-
TTTTGGCGTCTTCC.
The wild-type S16 and L30 TOP sequences were replaced by
the TOP sequence of L32. The primers listed below were used to
generate the mutated constructs S16 to L32, L30 to L32, L32 to
S16 and L32 to L30 (restriction enzyme sites are underlined (all
noted 59-39): 59S16-L32, ACGTACGCGTAAGCTTGCATG-
CACAGCTCCGC; 39S16-L32, ACGTCTCGAGGGATCCTC-
TAGCCACACCGCAGCGCCGCGACCGGAAGAAGGAAG-
AGGGGGCCAACCCAGCCGATTTT; 59L30-L32, ACGT-
ACGCGTAAGCTTCAGAACAAACGCCCAGA; 39L30-L32,
ACGTCTCGAGGGATCCTCTAGCCAGCCGCCAAGATGG-
CCGGGGAGCGGAAGAAGGAAGAGGTCCCACAATGCA-
AAGCTCTTCTA; 59L32-S16 and -L30, ACGTACGCGTA-
AGCTTGCATGCCTGCAGGT; 39L32-S16, ACGTCTCGAG-
GGATCCGGCAGCCACCTCGTAGGCAGCGCCGAGGAA-
AAGGGAAGCGCCGGCGGCGGCGCGCAAGG and 39L32-
L30, ACGTCTCGAGGGATCCGGCAGCCACCTCATGGG-
CAGCGCCGAGAGAAAGGAAGGAGCCGGCGGCGGCGC-
GCAAGG.
Luciferase assays
Cells were seeded in 6-well plates (5610
5 cells/well), transfected
with 2.5 mg of Firefly luciferase reporter and 250 ng of pRL-TK
(Renilla luciferase reporter) for transfection efficiency (Promega)
and were cultured for 32 hr. Cells were then induced to over-
express eIF4E by removing tetracycline for 16 hr. Transient
transfections with Lipofectamine Plus reagent (Invitrogen) were
performed according to the manufacturer’s protocol. Cells were
lysed, and luciferase assays were carried out according to a
standard protocol for the dual luciferase assay system (Promega).
SUPPORTING INFORMATION
Table S1 Transcriptionally regulated mRNAs in eIF4E-over-
expressing 3T3 cells. Total RNA from eIF4E-induced NIH 3T3-
tTA-eIF4E (-tet 5 hr) versus uninduced (+tet 5 hr) cells was
compared to 3T3-tTA cells with and without tetracycline. Genes
showing fold changes of .1.3 and SAM q,0.1 were considered
significant.
Found at: doi:10.1371/journal.pone.0000242.s001 (0.02 MB
XLS)
Table S2 Preliminary analysis of translationally activated genes.
The mRNAs that sedimented with polysomes from induced 3T3-
tTA-eIF4E (-tet 5 hr) cells were compared to total RNA from the
same cells. The ratios were normalized against those obtained by
comparing polysomal RNA of 3T3-tTA (-tet 5 hr) cells versus total
RNA from the same cells. Average fold changes of 1.5 and over
were considered significant.
Found at: doi:10.1371/journal.pone.0000242.s002 (0.11 MB
DOC)
Table S3 Translationally regulated mRNAs in eIF4E-over-
expressing 3T3 cells. Genes that experience a change in
polysomal/total RNA ratio between 3T3-tTA-eIF4E and 3T3-
tTA are shown. Fold changes of .1.3 and SAM q-value,0.1 were
considered significant.
Found at: doi:10.1371/journal.pone.0000242.s003 (0.14 MB
XLS)
Table S4 Functional analysis of translationally activated genes.
Genes that were translationally activated by induced eIF4E (SAM
q,0.1) were searched for overrepresentation of functional
categories as defined by the gene ontology consortium, the
UTRSite and the targetscan miRNA database.
Found at: doi:10.1371/journal.pone.0000242.s004 (0.03 MB
XLS)
Table S5 Functional analysis of translationally repressed genes.
Genes that were translationally repressed by induced eIF4E (SAM
q,0.1) were searched for overrepresentation of functional
categories as defined by the gene ontology consortium, the
UTRSite and the targetscan miRNA database.
Found at: doi:10.1371/journal.pone.0000242.s005 (0.03 MB
XLS)
Table S6 Summary table of ribosomal protein mRNA changes
induced by eIF4E overexpression. Results from the microarray
analyses (preliminary and final), figures 2, 3 and 4 for ribosomal
protein mRNAs are summarized.
Found at: doi:10.1371/journal.pone.0000242.s006 (0.02 MB
XLS)
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